# Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence

> **NCT07459946** · NA · NOT_YET_RECRUITING · sponsor: **Jiazhen Yin** · enrollment: 198 (estimated)

## Conditions studied

- Diabetic Nephropathy Type 2
- Chronic Renal Failure/ Kidney Disease

## Interventions

- **DRUG:** Jiajian Yishen Xiaozheng Qufeng Granules

## Key facts

- **NCT ID:** NCT07459946
- **Lead sponsor:** Jiazhen Yin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459946, "Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07459946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*